Y-Intercept (Hong Kong) 13F: Cuts CME Stake by $25M
Y-Intercept (Hong Kong) has cut its stake in CME Group Inc. significantly, as reflected in its recent 13F filing.
Reviewed by automated data checks against the source filing. How we make and check alerts
Y-Intercept (Hong Kong) sold 95,086 shares from its stake in CME Group Inc. ($CME), a 64.10% decrease, according to a 13F filing with the SEC dated October 16, 2026. It reported 53,259 shares worth $13.95 million at the end of the quarter.
CME
CME Group Inc.
Key Points
- Y-Intercept (Hong Kong) reduced its stake in CME Group Inc. by 95,086 shares, bringing its total to 53,259 shares worth approximately $13.95 million.
- CME Group shares recently traded around $290.33, which is above their 50-day and 200-day moving averages by 6.3% and 4.2%, respectively.
- Other institutional players like BlackRock and Vanguard have also adjusted their positions in CME, with BlackRock cutting its holdings by 880,512 shares.
Get $CME trade alerts by text
We text you when insiders, Congress or big funds trade $CME. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Y-Intercept (Hong Kong) has cut its stake in CME Group Inc. (CME) by 95,086 shares, leaving it with a total of 53,259 shares valued at approximately $13.95 million. This change was disclosed in a filing on October 16, 2026.
What Changed in Y-Intercept's CME Position
Y-Intercept reduced its holdings in CME Group by 64.1%. This cut means the firm does not hold a brand-new position, as it has been a shareholder in the company previously.
Other Institutional Activity in CME
Several major institutional investors adjusted their positions in CME Group during the same quarter. BlackRock Inc. cut its stake by 880,512 shares, ending with 30,566,342 shares valued at about $8.98 billion. Vanguard Capital Management LLC increased its stake by 294,430 shares to hold 23,661,856 shares, valued at approximately $6.95 billion. State Street Corporation also grew its holdings by 290,606 shares, totaling 16,346,170 shares worth about $4.8 billion.
CME Group Inc. Stock Up 0.3%
CME Group shares were recently trading around $290.33. This price is above both the 50-day and 200-day moving averages, which is generally a positive sign. However, it is approximately 11.8% below the 52-week high of $329.16.
Recent Earnings
For the trailing twelve months, CME Group reported revenue of approximately $6.76 billion, with an EPS of $11.79. The company has a net margin of 63.4% and a return on equity of 15.8%. CME Group is set to announce its next earnings on October 21, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Insider Buying and Selling at CME Group Inc.
Insider transactions reveal that on September 10, 2026, CEO Terrence A. Duffy sold 15,000 shares, valued at approximately $4.12 million. Other insiders have also made trades; Timothy Bitsberger bought 645 shares at $225.00 each on June 25, 2026, totaling about $145,125.
Analysts Set New Price Targets
Analysts are maintaining a mixed outlook on CME Group. On October 5, 2026, UBS kept a "Neutral" rating with a target price of $270. On the same day, TD Cowen maintained a "Buy" rating but raised its target to $300. Morgan Stanley, on October 9, 2026, maintained an "Overweight" rating with a target of $337.
About CME Group
CME Group Inc. is a major player in the financial services sector, operating markets for trading futures and options on futures globally. It provides products related to interest rates, equity indexes, foreign exchange, and various commodities. The recent changes in substantial shareholder positions reflect ongoing adjustments in market sentiment around the company.
Bottom Line
Investors should keep an eye on CME Group's upcoming earnings report on October 21, 2026, and further institutional activity, as the 13F filings provide insights into the investment strategies of major funds. Remember, these filings reflect positions from the previous quarter and may not represent current holdings.
Related Filing Alerts
Source: Y-Intercept (Hong Kong)'s 13F filing on $CME (Oct 16, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Read the original filing: 13F-HR filing on SEC EDGAR. Written by software, not financial advice. How we make alerts